ARTH's logo.
Ticker Symbol: ARTH

Arch Therapeutics Inc

Exchange: OTC MARKETS Currency: USD Asset Type: Common Stock CIK:0001537561

Company Profile

arch therapeutics, inc., together with its subsidiaries, operates as a biotechnology company in the united states. the company develops and markets products based on its ac5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. its flagship products include ac5 advanced wound system and ac5 topical hemostat, which are intended for skin applications, such as management of complicated chronic wounds or acute surgical wounds. the company was founded in 2006 and is based in framingham, massachusetts.

Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing
Standard Industrial Classification Code (SIC code): 3841
Address: N/A
Website: N/A
CEO: N/A
Tags:
  • Biotechnology
  • Health Technology
  • Distribution Services
  • Medical Distributors
  • Manufacturing
  • Surgical and Medical Instrument Manufacturing

Pricing

Last Updated: October 19, 2023 03:00 PM EST
Previous Close: $0.60
Change: $0.00 ( -0.02%)
Days Range: $0.60 - $0.65
Beta: -
52wk. High: $7.00
52wk. Low: $0.01
Ytd. Change 2207.68%
50 Day Moving Average: $1.19
200 Day Moving Average: $2.19
Shares Outstanding: 4689446

Valuation

Market Cap: 281.4M
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A